torpedo has been researched along with Chronic Disease in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (16.67) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Conti-Fine, BM; Milani, M; Okita, D; Ostlie, N; Wang, W | 1 |
| Abramsky, O; Argov, Z; Brenner, T; Zielinski, A | 1 |
| Barohn, RJ; Clarkin, KZ; Infante, AJ; Infante, PD; Iturriaga, E; Jackson, CE; Kraig, E; Krolick, KA; Talib, S; Tami, J | 1 |
| Agius, MA; Fairclough, RH; Zhu, S | 1 |
| Barchan, D; Fuchs, S; Im, SH; Maiti, PK; Souroujon, MC | 1 |
| Choe, S; Itano, A; Pachner, AR; Ricalton, N | 1 |
6 other study(ies) available for torpedo and Chronic Disease
| Article | Year |
|---|---|
Absence of IL-4 facilitates the development of chronic autoimmune myasthenia gravis in C57BL/6 mice.
Topics: Amino Acid Sequence; Animals; Autoantibodies; B7-1 Antigen; CD4-Positive T-Lymphocytes; CD40 Antigens; Chronic Disease; Epitopes, T-Lymphocyte; Genetic Predisposition to Disease; Immunization; Injections, Subcutaneous; Interferon-gamma; Interleukin-4; Lymphocyte Activation; Mice; Mice, Inbred C57BL; Mice, Knockout; Myasthenia Gravis, Autoimmune, Experimental; Peptide Fragments; Receptors, Cholinergic; Severity of Illness Index; Spleen; Torpedo | 2003 |
Prevention of experimental autoimmune myasthenia gravis in rats by fetal alpha-fetoprotein-rich fractions.
Topics: Acute Disease; alpha-Fetoproteins; Animals; Antibody Formation; Autoantibodies; Chronic Disease; Electromyography; Female; Fetus; Humans; Immunity, Cellular; Immunosuppressive Agents; Lymphocyte Activation; Muscle Denervation; Muscles; Myasthenia Gravis; Radioimmunoassay; Rats; Rats, Inbred Lew; Receptors, Cholinergic; Torpedo | 1984 |
Evidence against chronic antigen-specific T lymphocyte activation in myasthenia gravis.
Topics: Adult; Aged; Aged, 80 and over; Animals; Antibody Specificity; Chronic Disease; Clone Cells; Female; Flow Cytometry; Humans; Lymphocyte Activation; Male; Membrane Proteins; Middle Aged; Mutation; Myasthenia Gravis; Protein Structure, Tertiary; Receptors, Cholinergic; Receptors, Interleukin-2; Recombinant Proteins; Solubility; T-Lymphocytes; Torpedo | 1996 |
Antirapsyn antibodies in chronic procainamide-associated myopathy (CPAM).
Topics: Aged; Aged, 80 and over; Animals; Autoantibodies; Chronic Disease; Electric Organ; Enzyme-Linked Immunosorbent Assay; Humans; Male; Muscle Proteins; Neuromuscular Diseases; Procainamide; Receptors, Nicotinic; Torpedo | 1998 |
Blockade of CD40 ligand suppresses chronic experimental myasthenia gravis by down-regulation of Th1 differentiation and up-regulation of CTLA-4.
Topics: Abatacept; Animals; Antibody Specificity; Antigens, CD; Antigens, Differentiation; B-Lymphocytes; CD40 Ligand; Cell Differentiation; Cells, Cultured; Chronic Disease; CTLA-4 Antigen; Cytokines; Down-Regulation; Female; Humans; Hypersensitivity, Delayed; Immune Sera; Immunoconjugates; Immunoglobulin G; Immunoglobulin Isotypes; Immunosuppressive Agents; Injections, Intraperitoneal; Injections, Subcutaneous; Lymphocyte Activation; Myasthenia Gravis, Autoimmune, Experimental; Rats; Rats, Inbred Lew; Receptors, Cholinergic; Th1 Cells; Th2 Cells; Torpedo; Up-Regulation | 2001 |
Chronic murine experimental myasthenia gravis: strength testing and serology.
Topics: Animals; Autoantibodies; Autoimmune Diseases; Chronic Disease; Exercise Test; Female; Immunization; Mice; Mice, Inbred BALB C; Mice, Inbred C57BL; Myasthenia Gravis; Receptors, Cholinergic; Serum Albumin, Bovine; Torpedo | 1991 |